Evaluation of the Cost-effectiveness of Services for Schizophrenia in the UK Across the Entire Care Pathway in a Single Whole-Disease Model

IMPORTANCE: The existing economic models for schizophrenia often have 3 limitations; namely, they do not cover nonpharmacologic interventions, they report inconsistent conclusions for antipsychotics, and they have poor methodologic quality. OBJECTIVES: To develop a whole-disease model for schizophre...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Huajie, Tappenden, Paul, MacCabe, James H., Robinson, Stewart, Byford, Sarah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254180/
https://www.ncbi.nlm.nih.gov/pubmed/32459356
http://dx.doi.org/10.1001/jamanetworkopen.2020.5888

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254180/
https://www.ncbi.nlm.nih.gov/pubmed/32459356
http://dx.doi.org/10.1001/jamanetworkopen.2020.5888

Ejemplares similares